Characteristics of patients newly diagnosed with diabetes mellitus after Coronavirus disease-19 (COVID-19) | ||||
| Al-Azhar International Medical Journal | ||||
| Volume 2024, Issue 1, January 2024 | ||||
| DOI: 10.58675/2682-339X.2222 | ||||
 View on SCiNiTO | ||||
| Authors | ||||
| Alboraie Mohamed Aly; Megahed Mohamed Rabie; Abohasan Ahmed Mohamed; Abdelraouf Mahmoud Ezzat; Badr Gamal Aly | ||||
| Department of internal medicine, Faculty of Medicine, Al-Azhar University, Cairo, Egypt, | ||||
| Abstract | ||||
| Background: At this moment, there is a greater than ever level of concern over the 2019 (COVID-19) coronavirus illness pandemic and its related morbidities. Aim and objectives: Case series with systematic review of the frequency of newly diagnosed diabetes mellitus (DM) among COVID-19 patients, its varied symptoms, and glycemic control in diabetic patients. Patients and methodology: 100 patients altogether were split into two groups for this cross-sectional study. Every examination done at the time of diagnosis and two months afterwards. They were evacuated from Al-Hussein University Hospital between January and July 2022. Results: Our findings showed that the HbA1C levels two months after diagnosis and the HbA1C levels had statistically significant differences (at diagnosis). Fasting glucose, CRP, D-dimer, and random blood glucose measurements were higher upon diagnosis than two months after release. People who had steroid treatment had greater RBG levels than those who did not (Random Blood Glucose). Conclusion: Patients with more serious diseases were more likely to have newly diagnosed diabetes or have its symptoms during their illness, while COVID-19 subjects were more likely to do so. | ||||
|
Statistics Article View: 21 |
||||
